Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2025.06.27
ag真人平台官方：2024年年度权益分派实施公告
2025.06.17
ag真人平台官方：关于依诺肝素钠注射液获得EMA新增生产商批准的公告
2025.05.23
ag真人平台官方：2024年年度股东大会决议公告
2025.04.24
ag真人平台官方：监事会决议公告
2025.04.24
ag真人平台官方：关于依诺肝素钠注射液获得南非药品注册批件的公告
2025.04.24
ag真人平台官方：关于向全资子公司天道医药（香港）有限公司增资的进展公告
2025.04.24
ag真人平台官方：董事会决议公告
2025.04.24
ag真人平台官方：2025年一季度报告
2025.04.02
ag真人平台官方：关于举行2024年度业绩说明会的公告
2025.03.28
ag真人平台官方：年度关联方资金占用专项审计报告
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
